NASDAQ : LUNG
Pulmonx Corporation — Key statistics
Healthcare · Medical Devices · United States
Last price 3.165 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 135.93M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 129.06M |
| Enterprise Value | 132.72M |
Dates
| Measure | Value |
|---|
| Earnings Date | Oct 27, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 42.95M |
| Shares Outstanding | 42.95M |
| Shares Change (YoY) | +5.00% |
| Shares Change (QoQ) | +1.67% |
| Owned by Insiders (%) | 5.94% |
| Owned by Institutions (%) | 54.49% |
| Float | 37.61M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.45 |
| Forward PS | 1.33 |
| PB Ratio | 3.79 |
| P/TBV Ratio | 4.05 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 1.49 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 4.05 |
| Quick Ratio | 3.12 |
| Debt / Equity | 1.65 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -9.39 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -90.31% |
| Return on Assets (ROA) | -19.82% |
| Return on Invested Capital (ROIC) | -23.78% |
| Return on Capital Employed (ROCE) | -44.04% |
| Weighted Average Cost of Capital (WACC) | 6.03% |
| Revenue Per Employee | $299,916 |
| Profits Per Employee | -$143,760 |
| Employee Count | 296 |
| Asset Turnover | 0.71 |
| Inventory Turnover | 1.27 |
Taxes
| Measure | Value |
|---|
| Income Tax | 619,000 |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.34 |
| 52-Week Price Change | +56.51% |
| 50-Day Moving Average | 2.05 |
| 200-Day Moving Average | 1.66 |
| Relative Strength Index (RSI) | 76.78 |
| Average Volume (20 Days) | 1,024,491 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 698,644 |
| Short Previous Month | 802,733 |
| Short % of Shares Out | 1.63% |
| Short % of Float | 1.86% |
| Short Ratio (days to cover) | 2.60 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 88.78M |
| Gross Profit | 68.73M |
| Operating Income | -39.41M |
| Pretax Income | -41.93M |
| Net Income | -42.55M |
| EBITDA | -38.41M |
| EBIT | -39.41M |
| Loss Per Share | -$1.01 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 52.69M |
| Total Debt | 56.35M |
| Net Cash | -3.66M |
| Net Cash Per Share | -$0.09 |
| Equity (Book Value) | 34.20M |
| Book Value Per Share | 0.79 |
| Working Capital | 63.32M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -30.56M |
| Capital Expenditures | -112,000 |
| Depreciation & Amortization | 997,000 |
| Net Borrowing | 1.68M |
| Free Cash Flow | -30.67M |
| FCF Per Share | -$0.71 |
Margins
| Measure | Value |
|---|
| Gross Margin | 77.42% |
| Operating Margin | -44.39% |
| Pretax Margin | -47.24% |
| Profit Margin | -47.93% |
| EBITDA Margin | -43.27% |
| EBIT Margin | -44.39% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -5.00% |
| Shareholder Yield | -5.00% |
| Earnings Yield | -33.52% |
| FCF Yield | -23.76% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $3.70 |
| Price Target Difference | 23.13% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | 7.03% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -6.16 |
| Piotroski F-Score | 3 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |